# Comparison of Korean Botulinum Toxin Type A Versus Botox in the Treatment of Essential Blepharospasm

> **NCT00682760** · PHASE3 · COMPLETED · sponsor: **Pacific Pharmaceuticals** · enrollment: 60 (actual)

## Conditions studied

- Blepharospasm

## Interventions

- **DRUG:** Korean Botulinum toxin type A (KbtxA) and Botox injection

## Key facts

- **NCT ID:** NCT00682760
- **Lead sponsor:** Pacific Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2006-02
- **Final completion:** 2006-08
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2008-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00682760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00682760, "Comparison of Korean Botulinum Toxin Type A Versus Botox in the Treatment of Essential Blepharospasm". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT00682760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*